Şunu aradınız:: proprozjonali (Maltaca - İngilizce)

madankollu, ir-rekwiżiti mhumiex dejjem proprozjonali mar-riskji potenzjali, dan ifisser li l-ispejjeż ta' applikazzjoni jistgħu jitqiesu disproporzjonati.
however, the requirements are not always proportional to the potential risks, which mean that the costs of application could be considered disproportionate.

fi studji dwar il-firxa tad-doża, denosumab wera farmakokinetika mhux lineari u dipendenti mid- doża, bi tneħħija aktar baxxa b’dożi jew konċentrazzjonijiet ogħla, iżda b’żidiet fl-esponiment ftit jew wisq proprozjonali mad-doża għal dożi ta’ 60 mg jew aktar.
in dose ranging studies, denosumab exhibited non-linear, dose-dependent pharmacokinetics, with lower clearance at higher doses or concentrations, but approximately dose-proportional increases in exposures for doses of 60 mg and greater.